ATE343398T1 - Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge - Google Patents

Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge

Info

Publication number
ATE343398T1
ATE343398T1 AT02747880T AT02747880T ATE343398T1 AT E343398 T1 ATE343398 T1 AT E343398T1 AT 02747880 T AT02747880 T AT 02747880T AT 02747880 T AT02747880 T AT 02747880T AT E343398 T1 ATE343398 T1 AT E343398T1
Authority
AT
Austria
Prior art keywords
eye
compositions
methods
hyperimmune reactions
treating
Prior art date
Application number
AT02747880T
Other languages
English (en)
Inventor
Simon Skurkovich
Boris Skurkovich
Original Assignee
Advanced Biotherapy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Biotherapy Inc filed Critical Advanced Biotherapy Inc
Application granted granted Critical
Publication of ATE343398T1 publication Critical patent/ATE343398T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AT02747880T 2001-06-05 2002-06-04 Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge ATE343398T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29589501P 2001-06-05 2001-06-05
US09/894,287 US6534059B2 (en) 2001-06-05 2001-06-28 Compositions and methods for treating hyperimmune response in the eye

Publications (1)

Publication Number Publication Date
ATE343398T1 true ATE343398T1 (de) 2006-11-15

Family

ID=26969391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747880T ATE343398T1 (de) 2001-06-05 2002-06-04 Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge

Country Status (9)

Country Link
US (2) US6534059B2 (de)
EP (1) EP1401496B1 (de)
JP (1) JP2004532885A (de)
AT (1) ATE343398T1 (de)
AU (1) AU2002318175B2 (de)
CA (1) CA2449488C (de)
DE (1) DE60215649D1 (de)
HK (1) HK1063601A1 (de)
WO (1) WO2002098460A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6709655B2 (en) 2001-02-28 2004-03-23 Instituto Bioclon, S.A. De C.V. Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof
US6861056B2 (en) * 2001-06-05 2005-03-01 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
US6534059B2 (en) * 2001-06-05 2003-03-18 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
US6712976B2 (en) * 2001-09-13 2004-03-30 Abtech Industries, Inc. Dual-action decontamination system
US7335759B2 (en) 2002-12-02 2008-02-26 Universidad Nacional Autónoma de Méxica (UNAM) Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides
MXPA06000965A (es) * 2003-07-25 2007-05-04 Silanes Sa De Cv Lab Administracion de fragmentos f(ab??)2 de anticuerpos anti-citocinas.
DK1848744T3 (da) * 2005-01-27 2012-03-19 Novimmune Sa Humane anti-interferon-gamma-antistoffer og fremgangsmåder til anvendelse heraf
WO2006102654A1 (en) * 2005-03-24 2006-09-28 Washington University Reduction of ophthamologic neovascularization
US7381802B2 (en) * 2005-04-15 2008-06-03 Universidad Nacional Autónoma De México (UNAM) Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom
CN101489569A (zh) * 2006-06-12 2009-07-22 席拉坎有限责任公司 眼表面疾病的局部治疗
US8697046B2 (en) 2008-08-15 2014-04-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of administering interferon gamma to absorb fluid from the subretinal space
AU2016257023B2 (en) 2015-05-07 2022-06-30 Swedish Orphan Biovitrum Ag Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
US11091543B2 (en) 2015-05-07 2021-08-17 Swedish Orphan Biovitrum Ag Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
EP0243465A1 (de) 1985-10-25 1987-11-04 Vivian L. Mackay Verfahren zur verwendung von bar-1 zum abscheiden von fremdproteinen
DE3689123T2 (de) 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8905400D0 (en) * 1989-03-09 1989-04-19 Jonker Margreet Medicaments
ATE180408T1 (de) * 1991-10-04 1999-06-15 Us Health Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen
US5888511A (en) 1993-02-26 1999-03-30 Advanced Biotherapy Concepts, Inc. Treatment of autoimmune diseases, including AIDS
DE19535073C1 (de) * 1995-09-21 1997-02-20 Roland Dr Grosmann Verfahren zur künstlichen Inkubation von Hühnereiern
US6534059B2 (en) * 2001-06-05 2003-03-18 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
US6861056B2 (en) * 2001-06-05 2005-03-01 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye

Also Published As

Publication number Publication date
JP2004532885A (ja) 2004-10-28
EP1401496A1 (de) 2004-03-31
CA2449488C (en) 2010-02-09
CA2449488A1 (en) 2002-12-12
US20030224005A1 (en) 2003-12-04
EP1401496A4 (de) 2005-08-31
US6534059B2 (en) 2003-03-18
US7232568B2 (en) 2007-06-19
AU2002318175B2 (en) 2006-01-05
US20020182212A1 (en) 2002-12-05
WO2002098460A1 (en) 2002-12-12
EP1401496B1 (de) 2006-10-25
DE60215649D1 (de) 2006-12-07
HK1063601A1 (en) 2005-01-07

Similar Documents

Publication Publication Date Title
ATE343398T1 (de) Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
BR0316880A (pt) Anticorpos contra pd-1 e usos dos mesmos
DE69935133D1 (de) Antagoniste zur behandlung von cd11/cd18 adhäsionsrezeptor-vermittelten krankheiten
DE60005953D1 (de) Stapelbare statische mischelemente
WO2005016962A3 (en) Compositions and methods for the treatment of immune related diseases
ATE448775T1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
WO2005059106A3 (en) Interferon alpha antibodies and their uses
DE60335552D1 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE60229059D1 (de) Proteomimetische verbindungen und verfahren
DE69939312D1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
DE69325393D1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
ATE346867T1 (de) Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten
ATE360442T1 (de) Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen
DE602004021847D1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE423110T1 (de) Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
WO2004083382A3 (en) Compositions and methods for treating hyperimmune response in the eye
DE60024997D1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
WO2005016263A3 (en) Compositions and methods for treating hyperimmune response in the eye
DE602004031003D1 (de) Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties